Moderna (MRNA)

Cash & Equivalents

$1.72B

Quarterly · Period ending: · USD

MRNA logo

MRNA Cash & Equivalents

Latest reported$1.72B
MRNA Quarterly Cash & Equivalents (-$1.06B → $1.72B)
High-resolution chart · PNG

MRNA cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
1,723,000,000
1,908,000,000
2,595,000,000
1,132,000,000
1,279,000,000
1,623,000,000
1,927,000,000
1,644,000,000
2,478,000,000
2,051,000,000
2,907,000,000
2,932,000,000
3,801,000,000
3,441,000,000
3,205,000,000
3,027,000,000
2,873,000,000
5,048,000,000
6,848,000,000
5,550,000,000
5,603,000,000
5,442,000,000
2,624,000,000
1,505,581,000
1,761,629,000
391,720,000
235,876,000
173,711,000
151,624,000
502,934,000
658,364,000
167,060,000
140,619,000
-756,029,000
134,859,000
-1,058,138,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.